Sellindge Surgery

As you will be aware, NHS England is making tirzepatide (Mounjaro) available in a phased approached over the next few years. NICE guidelines say that in order to gain access to tirzepatide (Mounjaro) on the NHS, patients must also be referred on to a diet and exercise support programme.
 
Although it has been announced that it will become available in primary care settings from Monday, 23 June (for a specific patient cohort) arrangements are being made to mobilise a provider of the necessary Behavioural Support for Obesity Prescribing (BSOP) that is specified in the NICE guidelines.

Until this service is in place in Kent and Medway, it is not possible to prescribe tirzepatide (Mounjaro) in primary care.
 
Please also note there is no provider of tirzepatide (Mounjaro) available under right to choose.

Please click this link for more information
 
 
We will provide further information when it is available.